Hologic Inc (BSP:H1OL34)
R$ 447.04 0 (0%) Market Cap: 101.45 Bil Enterprise Value: 103.43 Bil PE Ratio: 23.07 PB Ratio: 3.47 GF Score: 86/100

Hologic Inc at Bank of America Merrill Lynch Health Care Conference Transcript

May 14, 2019 / 08:00PM GMT
Xiaoxiao Ma
BofA Merrill Lynch, Research Division - Associate

Hello, everyone. Thank you very much for being at our 2019 BofA Healthcare Conference. My name is Ivy Ma. I work on the life sciences tools and diagnostic team here at BofA. Iâm here on behalf of my senior analyst, Derik De Bruin, whoâs unfortunately recovering from surgery and couldnât travel today, but heâs in spirit with us here, and heâs also tracking it all in the webcast. And then with the [I I] season kicking off yesterday, I would just â putting a shameless plug here, please support life sciences tools and diagnostics team here at BofA. We would really appreciate any support and feedback.

With that in, moving on to more important stuff, for the next session here, we have Mike Watts from the Investor Relations at Hologic. We also have Rich on the floor here also from IR.

Mike, happy to have you here joining us this year.

Michael J. Watts
Hologic, Inc. - VP of IR & Corporate Communications

Yes. Thank you for having us. That was a great conference for us. And before we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot